Abbott Laboratories $ABT Holdings Reduced by Cidel Asset Management Inc.

robot
Abstract generation in progress

Cidel Asset Management Inc. recently reduced its stake in Abbott Laboratories (NYSE:ABT) by 4.1% in the fourth quarter, selling 13,616 shares and now owning 322,225 shares. Despite this reduction, Abbott Laboratories remains the 7th largest position in Cidel’s investment portfolio, representing 2.9% of its holdings. The article also details other institutional investor activities, recent insider transactions, analyst ratings, and the company’s financial performance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin